Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis

Höpker, K., Hagmann, H., Khurshid, S., Chen, S., Hasskamp, P., Seeger-Nukpezah, T., et al. (2012). AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis. EMBO Journal, 31(20), 3961-3975. doi:10.1038/emboj.2012.236.

Item is

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Höpker, Katja1, Autor
Hagmann, Henning1, Autor
Khurshid, Safiya1, Autor
Chen, Shuhua2, Autor           
Hasskamp, Pia1, Autor
Seeger-Nukpezah, Tamina1, Autor
Schilberg, Katharina1, Autor
Heukamp, Lukas1, Autor
Lamkemeyer, Tobias1, Autor
Sos, Martin L.2, Autor           
Thomas, Roman K.2, Autor           
Lowery, Drew1, Autor
Roels, Frederik1, Autor
Fischer, Matthias1, Autor
Liebau, Max C.1, Autor
Resch, Ulrike1, Autor
Kisner, Tülay1, Autor
Röther, Fabian1, Autor
Bartram, Malte P.1, Autor
Müller, Roman Ulrich1, Autor
Fabretti, Francesca1, AutorKurschat, Peter1, AutorSchumacher, Björn1, AutorGaestel, Matthias1, AutorMedema, Rene H.1, AutorYaffe, Michael B.1, AutorSchermer, Bernhard1, AutorReinhard, H. Christian1, AutorBenzing, Thomas1, Autor mehr..
Affiliations:
1a Department II of Internal Medicine, University Hospital of Cologne, Cologne, Germany b 1] Department II of Internal Medicine, University Hospital of Cologne, Cologne, Germany c Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany d 1] Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany e Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany f Institute of Pathology, University of Cologne, Cologne, Germany g 1] Max Planck Institute for Neurological Research with Klaus-Joachim-Züls-Laboratories of the Max Planck Society and the Medical Faculty of the University of Cologne, Cologne, Germany h Department of Translational Genomics, University of Cologne, Cologne, Germany i Howard Hughes Medical Institute, Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA j 1] Institute of Pathology, University of Cologne, Cologne, Germany k Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA l Department of Pediatrics, University Hospital of Cologne, Cologne, Germany m 1] Department of Pediatrics, University Hospital of Cologne, Cologne, Germany n Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany o Department of Dermatology, University Hospital of Cologne, Cologne, Germany p Systems Biology of Aging, University of Cologne, Cologne, Germany q Institute of Physiological Chemistry, Hannover Medical University, Hannover, Germany r Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands, ou_persistent22              
2Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656              

Inhalt

einblenden:

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2012
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: eDoc: 614877
DOI: 10.1038/emboj.2012.236
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: EMBO Journal
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 31 (20) Artikelnummer: - Start- / Endseite: 3961 - 3975 Identifikator: ISSN: 02614189